Achieve Life Sciences Inc (ACHV) |
|
8.27 -0.1 (-1.19%)
|
06-18 08:47 |
|
Open: |
8.33 |
Pre. Close: |
8.37 |
|
High:
|
8.57 |
Low:
|
8.241 |
|
Volume:
|
226,715 |
Market Cap:
|
78M |
|
|
|
|
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. The company is headquartered in Seattle, Washington and currently employs 13 full-time employees. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
8.583 - 8.643 |
8.643 - 8.689 |
|
Low:
|
8.085 - 8.166 |
8.166 - 8.227 |
|
Close:
|
8.16 - 8.268 |
8.268 - 8.35 |
|
Technical analysis |
as of: 2021-06-17 4:41:51 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 10.74 One year: 12.15 |
| Support: |
Support1: 7.24 Support2: 6.02 |
| Resistance: |
Resistance1: 9.19 Resistance2: 10.40 |
| Pivot: |
8.46  |
| Moving Average: |
MA(5): 8.55 MA(20): 8.45
MA(100): 11.03 MA(250): 9.74 |
| MACD: |
MACD(12,26): -0.30 Signal(9): -0.38 |
| Stochastic oscillator: |
%K(14,3): 61.59 %D(3): 66.93 |
| RSI: |
RSI(14): 39.23 |
| 52-week: |
High: 18.26 Low: 6.85 Change(%): 0.9 |
| Average Vol(K): |
3-Month: 12432 10-Days: 14480 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ACHV has closed above bottom band by 32.7%. Bollinger Bands are 66.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACHV's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 17 Jun 2021
Achieve Life Sciences Inc. (ACHV) falls -1.1950% for June 17 - Equities.com
Mon, 14 Jun 2021
We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully - Simply Wall St
Sun, 13 Jun 2021
Achieve Life Sciences, Inc. (ACHV) Fell Out Of Favor With Hedge Funds? - Yahoo Finance
Thu, 10 Jun 2021
Achieve Life Sciences Inc. (ACHV) gains 1.1660% for June 10 - Equities.com
Thu, 03 Jun 2021
Achieve Life Sciences (ACHV) Announces Allowance of US Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction - StreetInsider.com
Wed, 02 Jun 2021
Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
6 |
| Shares Float (M) |
6 |
|
% Held by Insiders
|
0.45 |
|
% Held by Institutions
|
18.84 |
|
Shares Short (K)
|
469 |
|
Shares Short P. Month (K)
|
437 |
Stock Financials |
|
EPS
|
-5.420 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
6.100 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-30.0 |
|
Return on Equity (ttm)
|
-53.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.356 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-1.53 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.36 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-3.78 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2020-07-30 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
